TNFAIP6 and ischemic stroke: Thus, emerging evidence provides insights into the potential use of TSG-6 as a peripheral biomarker for diagnostic and/or prognostic purposes, especially in the context of ischemic stroke, where the pathobiological relevance of this protein was also validated in patients.